<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01234376</url>
  </required_header>
  <id_info>
    <org_study_id>HN-0003</org_study_id>
    <nct_id>NCT01234376</nct_id>
  </id_info>
  <brief_title>Confocal Laser Endomicroscopy in Patients With Eosinophilic Esophagitis</brief_title>
  <official_title>Confocal Laser Endomicroscopy in Patients With Eosinophilic Esophagitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Confocal laser endomicroscopy enables in vivo microscopic imaging within the mucosa layer of&#xD;
      the gut at a subcellular resolution. Various studies have addressed the potential of&#xD;
      endomicroscopy for the in vivo diagnosis of esophageal squamous cell carcinoma, Barrett´s&#xD;
      esophagus and esophageal adenocarcinoma. Currently, there is only one case report from our&#xD;
      group who noted the utility of endomicroscopy for the in vivo diagnosis of eosinophilic&#xD;
      esophagitis.&#xD;
&#xD;
      The purpose of this study is to determine whether endomicroscopy is effective for the in vivo&#xD;
      diagnosis of eosinophilic esophagitis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2010</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of endomicroscopy for the in vivo diagnosis of eosinophilic esophagitis</measure>
    <time_frame>November 2010 - November 2012</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differentiation of mucosal alterations in patients with eosinophilic esophagitis compared to patients with gastroesophageal reflux disease.</measure>
    <time_frame>November 2010 - November 2012</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">45</enrollment>
  <condition>Eosinophilic Esophagitis</condition>
  <arm_group>
    <arm_group_label>Control patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with eosinophilic esophagitis</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Confocal laser endomicroscopy</intervention_name>
    <description>Confocal laser endomicroscopy</description>
    <arm_group_label>Control patients</arm_group_label>
    <arm_group_label>Patients with eosinophilic esophagitis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with eosinophilic esophagitis who underwent EGD for the evaluation of their&#xD;
        symptoms.&#xD;
&#xD;
        Control patients who underwent EGD because of other reasons.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
          -  Age 18-85 years&#xD;
&#xD;
          -  Ability of subjects to understand character and individual consequences of clinical&#xD;
             trial&#xD;
&#xD;
          -  Subjects undergoing EGD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to provide written informed consent&#xD;
&#xD;
          -  Severe Coagulopathy (Prothrombin time &lt; 50% of control, Partial thromboplastin time &gt;&#xD;
             50 s)&#xD;
&#xD;
          -  Impaired renal function (Creatinine &gt; 1.2 mg/dl)&#xD;
&#xD;
          -  Pregnancy or breast feeding&#xD;
&#xD;
          -  Active gastrointestinal bleeding&#xD;
&#xD;
          -  Known allergy to fluorescein, acriflavin or cresyl violet&#xD;
&#xD;
          -  Residing in institutions (e.g. prison)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markus F. Neurath, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of Erlangen-Nürnberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Helmut Neumann, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Erlangen-Nürnberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Erlangen-Nuremberg</name>
      <address>
        <city>Erlangen</city>
        <state>Bayern</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 2, 2010</study_first_submitted>
  <study_first_submitted_qc>November 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2010</study_first_posted>
  <last_update_submitted>December 10, 2020</last_update_submitted>
  <last_update_submitted_qc>December 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophagitis</mesh_term>
    <mesh_term>Eosinophilic Esophagitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

